Nearly 15 per cent of CSL’s global workforce will be reduced in the biggest shake-up of the company in decades aimed at “simplifying the business”. CSL employs about 30,000 staff globally. Its share ...

Australia's largest pharmaceutical company will cut 3000 jobs globally, with $20bn wiped from the company’s market value. Nearly 15 per cent of CSL’s global workforce will be reduced in the biggest ...

New $1.5 billion investment builds on over $3 billion already spent on CSL's U.S. operations since 2018 Expansion will create at least 300 new jobs and enhance production of plasma-derived therapies ...

CSL will outlay $1.5bn over the next five years in the US to grow its footprint of plasma therapy production, the latest pharma company to pour money into the country amid tariff threats.